EUR 1.47
(8.09%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2.44 Million EUR | -23.13% |
2022 | 3.18 Million EUR | 295.42% |
2021 | 805.87 Thousand EUR | 218.01% |
2020 | 253.41 Thousand EUR | -0.86% |
2019 | 255.6 Thousand EUR | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 1.54 Million EUR | 0.0% |
2023 Q2 | 526.85 Thousand EUR | 3.96% |
2023 FY | 1.37 Million EUR | -56.7% |
2023 Q3 | 718 Thousand EUR | 36.28% |
2023 Q1 | 506.77 Thousand EUR | -63.64% |
2023 Q4 | 718 Thousand EUR | 0.0% |
2022 Q3 | 859.57 Thousand EUR | 21.12% |
2022 Q2 | 709.67 Thousand EUR | 23.52% |
2022 Q1 | 574.53 Thousand EUR | 37.27% |
2022 FY | 3.18 Million EUR | 295.42% |
2022 Q4 | 1.39 Million EUR | 62.15% |
2021 FY | 805.87 Thousand EUR | 218.01% |
2021 Q1 | 120.63 Thousand EUR | 107.55% |
2021 Q4 | 418.53 Thousand EUR | 5.29% |
2021 Q3 | 397.5 Thousand EUR | 29.58% |
2021 Q2 | 306.76 Thousand EUR | 154.28% |
2020 Q1 | 78.01 Thousand EUR | 0.0% |
2020 Q4 | 58.12 Thousand EUR | 0.0% |
2020 FY | 253.41 Thousand EUR | -0.86% |
2020 Q3 | 58.12 Thousand EUR | -25.49% |
2020 Q2 | 78.01 Thousand EUR | -0.0% |
2019 FY | 255.6 Thousand EUR | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Affluent Medical SA | 11.86 Million EUR | 79.357% |
Bluelinea Société Anonyme | 11.43 Thousand EUR | -21314.075% |
Carmat SA | 21.54 Million EUR | 88.632% |
Diagnostic Medical Systems S.A. | 18.1 Million EUR | 86.473% |
Euromedis Groupe | 17.6 Million EUR | 86.089% |
Eurobio Scientific Société anonyme | 47.34 Million EUR | 94.826% |
Implanet S.A. | 9.29 Million EUR | 73.635% |
Median Technologies SA | 46.34 Million EUR | 94.714% |
SpineGuard SA | 7.35 Million EUR | 66.696% |
Theraclion SA | -1.08 Million EUR | 326.73% |
Euroapi S.A. | 398.9 Million EUR | 99.386% |
Guerbet SA | 550.79 Million EUR | 99.555% |
Ion Beam Applications SA | 128.02 Million EUR | 98.087% |
Koninklijke Philips N.V. | 5.84 Billion EUR | 99.958% |
Sequana Medical NV | 30.03 Million EUR | 91.846% |